JP Patent

JP2011511786A — 転移期前立腺癌を治療する方法

Assigned to フェリングインターナショナルセンターエス．アー． · Expires 2011-04-14 · 15y expired

What this patent protects

対象の転移期前立腺癌の治療のためのデガレリクスを含む組成物。【選択図】図１

USPTO Abstract

対象の転移期前立腺癌の治療のためのデガレリクスを含む組成物。【選択図】図１

Drugs covered by this patent

degarelix-acetate (DEGARELIX ACETATE)

Patent Metadata

Patent number: JP2011511786A
Jurisdiction: JP
Classification: —
Expires: 2011-04-14
Drug substance claim: No
Drug product claim: No
Assignee: フェリングインターナショナルセンターエス．アー．
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.